Keywords: impax, updates, lead, candidates, pharmaceuticals, brand, products

Impax updates on lead candidates

Article | 21 April 2009

Print This

Impax Pharmaceuticals, the brand products division of Impax Laboratories, has commenced a Phase III trial of IPX066 in Parkinson's disease ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in